Actions

FDA says J&J 1-dose shot prevents COVID; final decision soon

Johnson and Johnson COVID Vaccine- AP Images
Posted at 8:42 AM, Feb 24, 2021
and last updated 2021-02-24 08:43:02-05

An analysis by U.S. regulators says Johnson & Johnson's single-dose vaccine protects against COVID-19.

The report Wednesday confirmed that overall the vaccine is about 66% effective at preventing moderate to severe COVID-19.

On Friday, a panel of experts to the Food and Drug Administration will debate if the evidence is strong enough to recommend the long-anticipated shot.

The FDA is expected to make a final decision within days. If the FDA clears the J&J shot for U.S. use, it won’t boost vaccine supplies significantly right away.

Only a few million doses are expected to be ready for shipping in the first week.